Mono Pharmacare Limited Approves New Committee Structures, Appoints Statutory Auditor Ahead of EGM
Mono Pharmacare Limited's Board of Directors held a meeting on June 3, 2026, during which several key operational and governance decisions were approved. The board considered the appointment of an Additional Independent Director, the re-constitution of critical committees, appointed a new Statutory Auditor, and made plans for an upcoming Extraordinary General Meeting (EGM).Among the major appointments made by the Board was Ms. Nirmala Ranawat (DIN: 11309088), who was considered and approved as an Additional Independent Director of the company. Furthermore, M/s R K Mergu & Co, Chartered Accountant (FRN: 136876W), was appointed as the Statutory Auditor for the Financial Year 2025-26 to fill a casual vacancy, subject to member approval.
The Board also addressed the re-constitution of several key internal bodies. Decisions were made regarding the Nomination and Remuneration Committee, the Audit Committee, and the Stakeholder Committee.
In preparation for an Extraordinary General Meeting (EGM), the Board decided to convey the meeting and considered and approved the Draft Notice along with the Explanatory Statement. M/s Surana and Kothari Associates LLP was appointed as the Scrutinizer responsible for conducting the E-voting process in a fair and transparent manner for the company's EGM. The board also fixed the record date required for the purpose of the EGM.
The composition details of the newly constituted committees, effective from June 3, 2026, are as follows:
Nomination and Remuneration Committee Composition
| Sr. no | Name | Designation in the Committee |
|---|---|---|
| 1 | Drashti Rohit Chande (Non-Executive Independent Director) | Chairperson |
| 2 | Nirmala Ranawat (Non-Executive Independent Director) | Member |
| 3 | Chintan Trivedi (Non-Executive Independent Director) | Member |
Audit Committee Composition
| Sr. no | Name | Designation in the Committee |
|---|---|---|
| 1 | Nirmala Ranawat (Non-Executive Independent Director | Chairperson |
| 2 | Supal Lakhtariya (Non - Executive Director) | Member |
| 3 | Chintan Trivedi (Non-Executive Independent Director) | Member |
Stakeholder Relationship Committee Composition
| Sr. no | Name | Designation in the Committee |
|---|---|---|
| 1 | Supal Lakhtariya (Non - Executive Director) | Chairperson |
| 2 | Drashti Rohit Chande (Non-Executive Independent Director | Member |
| 3 | Chintan Trivedi (Non-Executive Independent Director) | Member |
MONOPHARMA Stock Price Movement
Mono Pharmacare Limited shares today slipped by 5.00% to settle at ₹11.4. The stock saw trading activity involving a volume of 4,000 shares in the post-market session.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.